Wonik Investment Partners

Wonik Investment Partners, formerly known as Hanmi Technology Investment Co., Ltd., is a private equity and venture capital firm specializing in investments in incubation, start-up, early and mid-stage companies, growth capital and corporate restructuring. The firm prefers to invest in gaming contents, electronic components, computer, telecommunications equipment, petroleum, energy, machinery and equipment industries. It seeks to exit through an IPO or merger and acquisition. Wonik Investment Partners was established in 1997 and is based in Seoul, South Korea.

Ji-Ho Bang

Senior Principal

Cho, Jeong-Woon

Managing Director

Cho Sung-woo

Managing Director

Yun-Min Choi

Senior Principal

Hee-Jun Kang

Senior Principal

Dong-su Kim

President

Ho-Sung Kim

Managing Director

Sang-Ok Lee

Senior Principal

Hyung-Woo Lee

Senior Managing Director

Yong-Sung Lee

CEO

Seok-Jae Lee

Vice President

Hyun-Ho Lee

Senior Principal

Pil-Young Lee

Managing Director

Si-Yoon Noh

Senior Principal

Dong-Seok Woo

Vice President

Yang, Chang-Mo

Senior Principal

Nam-Gyu Yu

Principal

32 past transactions

VSI

Series B in 2023
VSI provides essential networking solutions for next generation automotive and industrial applications.

Nex Eye

Series A in 2022
Nex Eye is a start-up that develops first-in-class antibodies targeting refractory factors of immuno-oncology drugs.

TODOC

Series B in 2022
TODOC is the technology leader of neural prosthesis and neuromodulation system in Korea. TODOC is developing cochlear implant system with innovative manufacturing method for implantable neural interface. People who have a hearing loss greater than 90dB are guided to use cochlear implant instead of hearing aids to restore hearing. Our goal is to expand the cochlear implant market globally. Because of the high price, cochlear implants are usually consumed in the developed countries such as North America and Europe. However, majority of the hearing-impaired population currently resides in the developing or underdeveloped countries where people cannot afford the benefit of the cochlear implant. This high price of the cochlear implant is mostly due to the manual method of manufacturing the neural electrodes. To replace the conventional manual fabrication method, TODOC has developed automated micro-machining electrode manufacturing processes at only 1/10 of conventional manufacturing cost of electrode, as well as the cochlear implant system. The automated electrode manufacturing processes can offer higher capacities for a wider range of sounds to the hearing impaired than conventional ones. TODOC aims to become a global leader in the Brain-Machine Interface field based on its superior Neural Interface Technology.

Astrogen

Series B in 2022
Astrogen is a biotech company developing new drugs.

Organoid Sciences

Series B in 2021
Organoid Sciences is an organoid-based treatment drug development company that offers drug screening and regenerative medicines.

Daily Beer

Series A in 2021
Daily Beer is a craft beer platform.

SIR.LOIN

Series B in 2021
SIR.LOIN is an e-commerce store for Korean beef.

Cenyx Biotech

Series A in 2021
Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.

Copin Communications

Series B in 2021
Copin Communications creates and design emoticon characters and character manuals. They also create webtoon genres such as fantasy, romance fantasy, romance, and BL. Their customers' inquiries are addressed by phone and email.

Standigm

Series C in 2021
Standigm is a workflow AI-driven drug discovery company. Standigm has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable drug pipelines. Founded in 2015, the company has established an early-stage drug discovery workflow AI to generate First-in-Class lead compounds within seven months. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactory™, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASK™ for target discovery, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing.

TerraLIX

Series A in 2021
TerraLIX is a manufacturer of fuel cell products.

AKIII Classic

Series A in 2020
AKIII Classic manufactures and sells shoes, clothes, tops, pants, bags, hats, and accessories.

DRX

Series A in 2020
DRX is an esports management organization and runs a professional League of Legends (LOL) team. It has a strong global fandom, which helped DRX reach 270k average viewers in this spring season and 3rd place in global viewership across all global LOL teams. DRX has developed a proprietary method of quantitative and qualitative metrics analysis upon which builds a structured team training system.

SN BioScience

Series B in 2020
SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA), peptide and protein to deliver in the form of nano-micelle, nanoparticle or liposome. Their proprietary “double core-shell technology” and pool of acceptable lipids and polymers could help your research that having difficulties in solubility or delivery.

Macaron M

Series A in 2020
Macaron M is a mobile application that offers taxi services.

ProtoPie

Series A in 2020
Prototyping interactions as easy as pie ProtoPie is an easy but powerful software that allows designers and engineers to plan, communicate, and demonstrate an interactive mobile product. Build a sophisticated prototype without any coding, but leveraging all the native mobile device features. The powerful capabilities are already recognized and adopted by the global top brands and such as Google, Microsoft, R/GA, and Ideo.

TeraView

Venture Round in 2020
TeraView is the world’s first company devoted to the application of Terahertz light for imaging and spectroscopy. TeraView’s proprietary platform uses the Terahertz spectrum between light and radio waves and offers the advantage of being non-invasive and non-destructive. A key application of the technology is the detection of faults and quality variations in semiconductor integrated circuits. In addition, studies have demonstrated how Terahertz uniquely and non invasively provides 3 dimensional structural and chemical information in a diverse range of applications, including weapons/explosives hidden below clothing, the contents of tablets and capsules in the pharmaceutical industry, and other objects normally invisible to conventional detection techniques. Other markets for the technology exist in medical imaging of cancer and industrial inspection which are explored via commercial partners. Headquartered in Cambridge, UK, TeraView was spun-out of the Toshiba Cambridge Research Laboratory in April 2001. Sales and support are available throughout Europe, North America and the Far East either directly or through a network of distributors.

Laseroptek

Venture Round in 2020
Laseroptek is a global developer and manufacturer of laser systems for tattoo removal, pigmentation, laser toning, and skin rejuvenation.

adoc

Seed Round in 2019
adoc provides medical records, discount medical examination, check AI symptoms and compare hospital expenses services.

Quantec

Series A in 2019
Quantec was founded in 2016 with the goal of ‘making easy and convenient asset management a daily possibility for everyone’. Through Quantec’s own technology called ‘Q-Engine’, users can analyze their actual assets and receive recommendation of variety of products suitable for their investment environment, or they can modify their own assets to construct a customized asset management portfolio. Based on ‘Q-Engine’, we are planning to launch the platform ‘Quantec (B2C Application)’ for general customers. In recognition of ‘Q-Engine’, Quantec has led to the selection of the fourth ‘Shinhan Future’s Lab’ by Shinhan Financial Group, the fourth ‘Dreamplus’ by Hanhwa Life Insurance, 'KB Starters' by KB Innovation HUB, the fourth 'NH Digital Challenge+' by NH Bank, and has attracted a Series A and Series B investments of total KRW 11 billion from Industrial Bank of Korea, Wonik Investment Partners, AG Investment, and Shinhan Capital. Via QUANTEC's asset management platform Quantec (App) and among other solutions, you will be able to meet your own private banker at any time, from anywhere!

Standigm

Series B in 2019
Standigm is a workflow AI-driven drug discovery company. Standigm has proprietary AI platforms encompassing novel target identification to lead generation to generate commercially valuable drug pipelines. Founded in 2015, the company has established an early-stage drug discovery workflow AI to generate First-in-Class lead compounds within seven months. Pursuing full-stack, AI-driven industrializing drug discovery, Standigm has achieved the automation of molecular design workflow through DarkMolFactory™, and the automation effort has been expanding to the whole drug discovery process on the basis of Standigm AI platforms, including Standigm ASK™ for target discovery, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing.

Amyloid Solution

Series A in 2019
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease progression and its underlying mechanism to find novel therapeutics, enabling clients with the best solution for Alzheimer disease.

Blocko

Series B in 2018
Blocko is a commercial blockchain startup offering multinational organizations the ability to design, deploy, and manage digital services on a secure distributed network. It provides a blockchain operating system and a development platform with stable APIs. The company supports AERGO, a new open-source enterprise blockchain solution based on a hybrid blockchain design with advanced cloud deployment capabilities.

Flexigo

Seed Round in 2018
Flexigo provides R&D, manufacturing, and test services for flexible display panel/component/material evaluation inspection facilities.

Blocko

Series A in 2017
Blocko is a commercial blockchain startup offering multinational organizations the ability to design, deploy, and manage digital services on a secure distributed network. It provides a blockchain operating system and a development platform with stable APIs. The company supports AERGO, a new open-source enterprise blockchain solution based on a hybrid blockchain design with advanced cloud deployment capabilities.

Poing

Series B in 2017
Poing is a restaurant service platform that provides online search and reservation for customers and management solutions for owners.

SEWORKS

Series A in 2016
We specialize in Web Application and API penetration Testing, Cyber Threat Intelligence, and Detecting Account Takeovers (ATOs) from attackers. Our DNA is rooted in offensive security, enabling our customers to discover vulnerabilities from an attacker's perspective.

Genoplan

Series A in 2016
Genoplan's mission is to democratize healthcare by harnessing the power of population genomics and deep learning. The company is dedicated to making genomics widely accessible, offering tools and analytics that empower individuals to make informed health decisions. Ultimately, Genoplan aims to contribute to the advancement of precision medicine while helping people take control of their well-being.

Lion Games

Series B in 2014
Lion Games is a Korean online game development company that serves the global content market. It was founded in 2011 and is based in Seoul, Seoul-t’ukpyols.

Justnine

Series B in 2013
Justnine Co. Ltd is a mobile app developer company and developed apps like HELLKID : hook & jum

Lion Games

Seed Round in 2013
Lion Games is a Korean online game development company that serves the global content market. It was founded in 2011 and is based in Seoul, Seoul-t’ukpyols.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.